A detailed history of Belpointe Asset Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Belpointe Asset Management LLC holds 12,602 shares of MRK stock, worth $1.25 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
12,602
Previous 15,100 16.54%
Holding current value
$1.25 Million
Previous $1.87 Million 23.43%
% of portfolio
0.1%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $277,652 - $322,167
-2,498 Reduced 16.54%
12,602 $1.43 Million
Q2 2024

Aug 02, 2024

BUY
$123.8 - $132.96 $140,760 - $151,175
1,137 Added 8.14%
15,100 $1.87 Million
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $52,316 - $60,960
462 Added 3.42%
13,963 $1.84 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $183,229 - $199,397
-1,829 Reduced 11.93%
13,501 $1.47 Million
Q3 2023

Nov 15, 2023

SELL
$102.95 - $114.33 $93,272 - $103,582
-906 Reduced 5.58%
15,330 $1.58 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $3.19 Million - $3.48 Million
-29,359 Reduced 64.39%
16,236 $1.87 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $615,890 - $687,207
-5,983 Reduced 11.6%
45,595 $4.85 Million
Q4 2022

Feb 08, 2023

BUY
$87.44 - $112.11 $948,461 - $1.22 Million
10,847 Added 26.63%
51,578 $5.72 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $331,611 - $372,528
3,923 Added 10.66%
40,731 $3.51 Million
Q2 2022

Aug 02, 2022

SELL
$83.49 - $94.64 $616,323 - $698,632
-7,382 Reduced 16.71%
36,808 $3.36 Million
Q1 2022

Apr 28, 2022

BUY
$73.51 - $82.4 $700,844 - $785,601
9,534 Added 27.51%
44,190 $3.62 Million
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $8,745 - $10,955
121 Added 0.35%
34,656 $2.66 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $159,416 - $175,317
2,224 Added 6.88%
34,535 $2.59 Million
Q2 2021

Aug 09, 2021

BUY
$70.31 - $77.77 $192,086 - $212,467
2,732 Added 9.24%
32,311 $2.51 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $49,579 - $58,399
-720 Reduced 2.38%
29,579 $2.28 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $665,020 - $738,036
9,266 Added 44.05%
30,299 $2.48 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $463,302 - $525,156
6,331 Added 30.1%
27,365 $2.11 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $463,375 - $525,239
-6,332 Reduced 23.14%
21,033 $1.75 Million
Q2 2020

Jul 20, 2020

SELL
$70.42 - $80.13 $445,829 - $507,303
-6,331 Reduced 23.14%
21,034 $1.63 Million
Q1 2020

Jul 20, 2020

SELL
$63.36 - $87.82 $54,552 - $75,613
-861 Reduced 3.05%
27,365 $2.11 Million
Q4 2019

Feb 18, 2020

BUY
$77.58 - $87.54 $536,077 - $604,901
6,910 Added 32.42%
28,226 $2.57 Million
Q3 2019

Jan 16, 2020

BUY
$76.08 - $82.93 $151,170 - $164,781
1,987 Added 10.28%
21,316 $1.79 Million
Q2 2019

Nov 22, 2019

BUY
$69.84 - $81.59 $199,812 - $233,428
2,861 Added 17.37%
19,329 $0
Q1 2019

Jun 11, 2019

BUY
$69.58 - $79.36 $384,359 - $438,384
5,524 Added 50.48%
16,468 $1.37 Million
Q4 2018

Mar 06, 2019

SELL
$65.24 - $75.71 $233,950 - $271,496
-3,586 Reduced 24.68%
10,944 $836,000
Q3 2018

Nov 23, 2018

BUY
$57.69 - $67.84 $371,927 - $437,364
6,447 Added 79.76%
14,530 $1.03 Million
Q2 2018

Aug 06, 2018

SELL
$50.83 - $59.72 $3,761 - $4,419
-74 Reduced 0.91%
8,083 $491,000
Q1 2018

Aug 06, 2018

BUY
$50.96 - $59.23 $72,719 - $84,521
1,427 Added 21.2%
8,157 $444,000
Q4 2017

Feb 15, 2018

SELL
$51.62 - $61.64 $63,647 - $76,002
-1,233 Reduced 15.48%
6,730 $379,000
Q3 2017

Nov 16, 2017

BUY
$58.67 - $63.13 $467,189 - $502,704
7,963
7,963 $510,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.